semaglutide cardiovascular outcomes 2025 news Recent study at UC Irvine found that medication may benefit 93 million U.S. adults What Ozempic and other GLP-1

Nrf2 is the principal transcription factor in charge of protecting cells from oxidative stress through the regulation of cytoprotective genes, including the antioxidant GSH pathway, that controls GSH homeostasis by affecting de novo synthesis

Journal Of The American College Of Cardiology 2026, 87: 987-989

They bind to the same receptors and produce similar outcomes: increased insulin release reduced appetite slower gastric emptying improved blood-sugar control For people with severe insulin resistance or poorly controlled diabetes, these medications can be extremely helpful in the short term

You may struggle to finish meals